Klacid Paediatric Suspension 125mg/5ml, Granules for Oral Suspension माल्टा - अंग्रेज़ी - Medicines Authority

klacid paediatric suspension 125mg/5ml, granules for oral suspension

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - granules for oral suspension - clarithromycin 125 mg/5ml - antibacterials for systemic use

Klacid 250mg/5ml Granules for Oral Suspension माल्टा - अंग्रेज़ी - Medicines Authority

klacid 250mg/5ml granules for oral suspension

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - granules for oral suspension - clarithromycin 250 mg/5ml - antibacterials for systemic use

Klacid 250mg/5ml Granules for Oral Suspension आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

klacid 250mg/5ml granules for oral suspension

viatris healthcare limited - clarithromycin - granules for oral suspension - macrolides; clarithromycin

Klacid न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

klacid

viatris limited - clarithromycin 25 mg/ml;  ;   - granules for oral suspension - 125 mg/5ml - active: clarithromycin 25 mg/ml     excipient: carbomer castor oil citric acid monohydrate fruit mix flavour wl-18758 204264 hydrated silica hypromellose phthalate maltodextrin potassium sorbate povidone sucrose titanium dioxide xanthan gum - klacid suspension is indicated for treatment of infections caused by susceptible organisms. such infections include: ? upper respiratory infections (e.g. streptococcal pharyngitis). ? lower respiratory infections (e.g. bronchitis, pneumonia). ? acute otitis media. ? skin and skin structure infections (e.g. impetigo, folliculitis, cellulitis, abscesses). ? disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localised infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii.